Jacob van Naarden, EVP & President, Lilly Oncology at ELI LILLY & Co (LLY), bought 1,000 shares at $647.36 ($647K) on 2025-08-13, disclosed to the SEC on 2025-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LOXO | SELL | 2018-10-05 | $2.0M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $2.8M | — | Filing → |
| LOXO | SELL | 2018-08-15 | $2.9M | — | Filing → |